SkinBioTherapeutics (GB:SBTX) has released an update.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
In a significant update from SkinBioTherapeutics PLC, David Campbell Brierwood has crossed a threshold in voting rights, now holding 3.1% of the company with 6,998,305 total voting rights as of August 12, 2024. This change in shareholding structure was formally notified to the company on the following day. No voting rights are held through financial instruments, indicating a straightforward equity stake.
For further insights into GB:SBTX stock, check out TipRanks’ Stock Analysis page.